248 related articles for article (PubMed ID: 11817706)
1. Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft.
Stefanik DF; Fellows WK; Rizkalla LR; Rizkalla WM; Stefanik PP; Deleo AB; Welch WC
J Neurooncol; 2001 Nov; 55(2):91-100. PubMed ID: 11817706
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor as a marker of tumor endothelium.
Brekken RA; Huang X; King SW; Thorpe PE
Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
Plate KH; Breier G; Weich HA; Mennel HD; Risau W
Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
[TBL] [Abstract][Full Text] [Related]
4. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.
Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA
Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835
[TBL] [Abstract][Full Text] [Related]
5. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors.
Schlaeppi JM; Wood JM
Cancer Metastasis Rev; 1999; 18(4):473-81. PubMed ID: 10855790
[TBL] [Abstract][Full Text] [Related]
6. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.
Plate KH; Breier G; Millauer B; Ullrich A; Risau W
Cancer Res; 1993 Dec; 53(23):5822-7. PubMed ID: 7694795
[TBL] [Abstract][Full Text] [Related]
8. [The influence of vascular endothelial growth factor and its receptor on the growth of laryngeal cancer cell].
Deng Z; Huang W; Jin Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 12(8):358-61. PubMed ID: 11263158
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.
Kunkel P; Ulbricht U; Bohlen P; Brockmann MA; Fillbrandt R; Stavrou D; Westphal M; Lamszus K
Cancer Res; 2001 Sep; 61(18):6624-8. PubMed ID: 11559524
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
13. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor.
Asano M; Yukita A; Suzuki H
Jpn J Cancer Res; 1999 Jan; 90(1):93-100. PubMed ID: 10076571
[TBL] [Abstract][Full Text] [Related]
14. KDR activation in astrocytic neoplasms.
Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
[TBL] [Abstract][Full Text] [Related]
15. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
[TBL] [Abstract][Full Text] [Related]
16. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
[TBL] [Abstract][Full Text] [Related]
18. Delayed vascular changes after antiangiogenic therapy with antivascular endothelial growth factor antibodies in human glioma xenografts in nude mice.
Bernsen HJ; Rijken PF; Peters JP; Bakker H; van der Kogel AJ
Neurosurgery; 1998 Sep; 43(3):570-5; discussion 575-6. PubMed ID: 9733312
[TBL] [Abstract][Full Text] [Related]
19. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
Warren RS; Yuan H; Matli MR; Gillett NA; Ferrara N
J Clin Invest; 1995 Apr; 95(4):1789-97. PubMed ID: 7535799
[TBL] [Abstract][Full Text] [Related]
20. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
Presta LG; Chen H; O'Connor SJ; Chisholm V; Meng YG; Krummen L; Winkler M; Ferrara N
Cancer Res; 1997 Oct; 57(20):4593-9. PubMed ID: 9377574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
